1. supply of medicinal products for the treatment of patients under the Multiple Sclerosis (MS) drug treatment programme and the botulinum toxin treatment programme.
2. The Contracting Authority allows for the possibility of submitting partial bids for individual tasks in accordance with Annex. No. 2 to SWZ constituting an assortment and price form. The Contracting Authority allows submission of partial bids for the following tasks:
Task No. 1 — Interferon beta -1a
Task No. 2 — Interferon beta — 1b
Task No. 3 — Dimethyl Fumarate
Task No. 4 — interferon beta — 1a
Task No. 5 — peginterferon beta-1a
Task No. 6 — teriflunamide
Task No. 7 — fingolimod
Task No 8 — cladribine
Task No. 9 — natalizumab
Exercise 10 – Ocrelizumab
Exercise No. 11 – Glatirameri acetas
Quest No. 12 – Sipominod
Task No. 13 – Ofatumumab
Exercise No. 14 – Ponesimod
Task No. 15 – Ozanimod
Exercise No. 16 – Clostridium botulinum type A
Exercise No. 17 – Clostridium botulinum type A
Exercise No. 18 – Clostridium botulinu
Task No. 1Task No. 1 — Interferon beta -1a
Task No. 10Exercise 10 – Ocrelizumab
Task No. 11Exercise No. 11 – Glatirameri acetas
Task No. 12Quest No. 12 – Sipominod
Task No. 13Task No. 13 – Ofatumumab
Task No. 14Exercise No. 14 – Ponesimod
Task No. 15Task No. 15 – Ozanimod
Task No. 16Exercise No. 16 – Clostridium botulinum type A
Task No. 17Exercise No. 17 – Clostridium botulinum type A
Task No. 18Exercise No. 18 – Clostridium botulinum type A
Task No. 2Task No. 2 — Interferon beta — 1b
Exercise NR 3Task No. 3 — Dimethyl Fumarate
Task No. 4Task No. 4 — interferon beta — 1a
Task No. 5Task No. 5 — peginterferon beta-1a
Task No. 6Task No. 6 — teriflunamide
Task No. 7Task No. 7 — fingolimod
Task No. 8Task No 8 — cladribine
Task No. 9Task No. 9 — natalizumab